# Replimune Group, Inc.: Form 8-K, filed May 10, 2021

- Company: [Replimune Group, Inc.](/companies/repl.md) (CIK 1737953)
- Form: 8-K
- Filed: 2021-05-10
- Accepted by EDGAR: May 10, 2021, 08:45 ET
- Period: 2021-05-07
- Accession: 0001104659-21-063503
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1737953/000110465921063503/tm2115722d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737953/000110465921063503/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737953/000110465921063503/tm2115722d1_8k.htm

Filed May 10, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-063503. Last ingested by Listed: Nov 11, 2026, 01:43 ET. No prices; not investment advice.
